Janssen Accused of Withholding Data on Risperdal Side Effect in Autism

Janssen Accused of Withholding Data on Risperdal Side Effect in Autism

Janssen Pharmaceuticals, manufacturer of a drug widely used in autistic children, omitted data on its side effects from a 2003 study, according to evidence presented during a lawsuit against the company.

Risperidone, marketed by Janssen as Risperdal, is one of only two drugs approved for autism. It was developed as an antipsychotic for adults with schizophrenia in 1993. Initially, it was not deemed safe for prepubescent children because it can boost levels of prolactin. Elevated prolactin levels are linked to a range of side effects, including gynecomastia in men and boys.


About TriMark

TriMark Legal Funding provides Risperdal pre settlement funding to injured plaintiffs nationwide.

This post originally appeared here: https://www.medpagetoday.com/neurology/autism/53288

Click here to see the full original article.

Still have questions?

Call (877) 932-2628 and speak with one of our legal funding experts.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in plaintiffs’ legal claims. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408